MMAE (Monomethyl auristatin E) is a potent microtubule inhibitor. It affects microtubule dynamics signaling by binding to and disrupting the microtubule network, effectively inducing G2/M cell cycle arrest and apoptosis in cancer cells.
MMAE (Monomethyl auristatin E) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for MMAE (Monomethyl auristatin E) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- MMAE (Monomethyl auristatin E) Mechanism of Action: Tubulin Inhibition in Cancer Cell Research
- MMAE (Monomethyl auristatin E) Clinical Trials
- MMAE (Monomethyl auristatin E): Selectivity & Specificity
- MMAE (Monomethyl auristatin E) Working Concentration | Cell Culture | Treatment
- MMAE (Monomethyl auristatin E) Solubility in DMSO
- MMAE (Monomethyl auristatin E) Stock Solution
- MMAE (Monomethyl auristatin E) Storage
- MMAE (Monomethyl auristatin E) Stability
- MMAE (Monomethyl auristatin E) Combination Database
- MMAE (Monomethyl auristatin E) Molecular Weight
- MMAE (Monomethyl auristatin E) SMILES
- MMAE (Monomethyl auristatin E) CAS Number
- MMAE (Monomethyl auristatin E) Chemical Structure (2D and 3D)
- MMAE (Monomethyl auristatin E) Sigma (SML3199)? Try a better option.
- MMAE (Monomethyl auristatin E) MedChemExpress (HY-15162)? Try a better option.
- MMAE (Monomethyl auristatin E) Cayman (16267)? Try a better option.
- MMAE (Monomethyl auristatin E) APExBIO (A3631)? Try a better option.
- MMAE (Monomethyl auristatin E) SDS｜MSDS